Search clinical trials for: LAG-3
Total 18113 results
-
Regeneron PharmaceuticalsSanofiCompletedHypercholesterolemiaUnited States, France, Italy, Germany, Spain, Canada, United Kingdom, Australia, Mexico
-
GeropharmCompletedBioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia)BioequivalenceRussian Federation
-
GeropharmCompletedBioequivalenceRussian Federation
-
Astellas Pharma IncCompletedKidney TransplantationChina
-
Ataturk UniversityCompleted3rd Level Intensive Care UnitTurkey
-
Keck School of Medicine of USCNot yet recruiting
-
GeropharmCompleted
-
SymateseUnknownThird-degree Burns | Reconstructive SurgeryFrance
-
Universitaire Ziekenhuizen KU LeuvenCompletedCondition of Patient 3 Years After FESS-operationBelgium
-
Memorial University of NewfoundlandCompletedThird Stage of LabourCanada
-
Poitiers University HospitalActive, not recruitingSchatzker Type 2 or 3 Tibial Plateau FractureFrance, Martinique
-
University of California, Los AngelesNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHuman Papillomavirus | CIN 3 | CIN 2United States
-
Gdansk University of Physical Education and SportUniversity of Southampton; Medical University of GdanskCompletedEffect of Omega-3 Supplementation on Exercise Performance and Muscle Tissue FunctionsPoland
-
Science and Research Centre KoperUniversity of Trieste; University of Franche-ComtéUnknownHealthy
-
Indonesia UniversityRecruitingBurn Degree Second | Burn Degree ThirdIndonesia
-
Ruhr University of BochumCompleted
-
Rabin Medical CenterOmega 3 GalileeRecruiting
-
3-C Institute for Social DevelopmentCompletedSocial Skills | Trauma, Psychological | Family DysfunctionalUnited States
-
3-C Institute for Social DevelopmentCompletedDiabetes Mellitus, Type 1United States
-
3-C Institute for Social DevelopmentCompletedRenal Insufficiency, ChronicUnited States
-
University of North Carolina, Chapel Hill3-C Family ServicesCompleted
-
ASLAN PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Australia, Singapore
-
GeropharmCompletedPharmacokinetics | BioequivalenceRussian Federation
-
University Hospital, Strasbourg, FranceUnknown
-
UCB Japan Co. Ltd.CompletedEpilepsy | Partial Onset SeizuresJapan
-
Centre Hospitalier Universitaire de NiceCompletedAdult Chronic Haemodialysis Patients Since at Least 3 MonthsFrance
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
BayerActive, not recruitingHemophilia ACanada, Japan, Spain, United States, Germany, Sweden, Belgium, Brazil, Greece, Italy, Netherlands, Taiwan, Denmark, Kuwait, Saudi Arabia, United Arab Emirates, Norway, Colombia, Switzerland, Slovenia
-
National Heart, Lung, and Blood Institute (NHLBI)UnknownSleep Disorders, Circadian RhythmUnited States
-
Linkoeping UniversityArmauer Hansen Research Institute, Ethiopia; University of GondarCompleted
-
Mahidol UniversityBayer; Chulalongkorn University; Bumrungrad International HospitalCompletedCarcinoma, HepatocellularThailand
-
Linkoeping UniversityKalmar County Hospital; University of GondarCompleted
-
Gomel State Medical UniversityRecruiting
-
NovartisNovartis VaccinesCompleted
-
Novartis VaccinesCompletedSeasonal Influenza, VaccineGermany
-
3-C Institute for Social DevelopmentCompleted
-
3-C Institute for Social DevelopmentCompletedSubstance-Related DisordersUnited States
-
Centre Oscar LambretUniversité Lille 3Completed
-
Michael PfeilstöckerCelgene CorporationCompletedMyelodysplastic SyndromesAustria
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Sir Run Run Shaw HospitalCompleted
-
Eisai Inc.CompletedInsomnia DisorderUnited States, Canada, Finland, Germany, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Spain
-
Merz North America, Inc.CompletedCorrection of Volume Loss in the Infraorbital Hollow AreaUnited States
-
Corregene Biotechnology Co., LtdRecruitingCervical Cancer | Anal Cancer | Head and Neck CancersChina
-
Allievex CorporationCompletedMucopolysaccharidosis Type IIIB | Mucopolysaccharidosis Type 3 B | MPS III B | MPS 3 BUnited States, Spain, Turkey, Taiwan, Australia, Colombia, Germany, United Kingdom
-
Memorial Sloan Kettering Cancer CenterChugai Pharma USARecruitingPrimary Extra-cranial Solid Tumor | Recurrent or Refractory Glypican 3 (GPC3)United States
-
October 6 UniversityCompletedPeriodontitis (Stage 3)Egypt
-
Eisai Inc.BiogenActive, not recruitingAlzheimer's DiseaseUnited States, Canada, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, United Kingdom